Editas Medicine (EDIT) Other Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Other Non-Current Assets data on file, last reported at $3.0 million in Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $3.0 million, down 43.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (down 43.02% YoY), and the FY2025 annual result was $3.0 million, down 43.02% from the prior year.
• Other Non-Current Assets held at $3.0 million in Q4 2025 per EDIT's latest filing, from $3.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $9.5 million in Q1 2024 and troughed at $3.0 million in Q4 2025.
• A 5-year average of $6.2 million and a median of $6.7 million in 2021 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2025: Other Non-Current Assets soared 179.72% in 2021, then slumped 55.75% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $6.8 million in 2021, then slipped by 22.87% to $5.3 million in 2022, then jumped by 63.49% to $8.6 million in 2023, then slumped by 39.18% to $5.2 million in 2024, then tumbled by 43.02% to $3.0 million in 2025.
• Business Quant data shows EDIT's Other Non-Current Assets at $3.0 million in Q4 2025, $3.0 million in Q3 2025, and $4.2 million in Q2 2025.